Nuclear Medicine
DISIDA
Name:
Disida SN Radiofarma – Tc
Active Principle:
Ácido Disopropiliminodiacetico
Therapeutic Action:
It is indicated to evaluate the bile ducts by scintigraphy and quantify duodenal gastric reflux, assess the functional status of hepatic polygonal cells in case of acute or chronic cholecystitis, liver disease with or without jaundice, complete or incomplete choledochal syndromes, biliary tract atresias, fistulas bile ducts, patency control of biliodigestive anastomoses, gallbladder motor function, suspicion of hepatic hematoma or adenoma.
Nuclear Medicine
DISIDA
Name:
Disida SN Radiofarma – Tc
Active Principle:
Ácido Disopropiliminodiacetico
Therapeutic Action:
It is indicated to evaluate the bile ducts by scintigraphy and quantify duodenal gastric reflux, assess the functional status of hepatic polygonal cells in case of acute or chronic cholecystitis, liver disease with or without jaundice, complete or incomplete choledochal syndromes, biliary tract atresias, fistulas bile ducts, patency control of biliodigestive anastomoses, gallbladder motor function, suspicion of hepatic hematoma or adenoma.
RELATED PRODUCTS
-
PYROPHOSPHATE
PYROPHOSPHATEIt is indicated for performing bone scintigraphy, detection of cardiac pathologies and "in vivo" and "in vitro" marking of erythrocytes. 1) In vivo, in vitro or in vivo/in vitro marking of red blood cells to... -
123I MIBG BACON (R&D)
123I MIBG BACON (R&D)It is indicated for: Oncology: a) Scintigraphic localization of tumors originating in tissues that derive embryologically from the neural crest...

